The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice. Xin-Jun Wu; Karen A. Oppelt; Ming Fan; Mona A. Marie; Madison M. Swyers; Ashley J. Williams; Isabelle M. Lemasson; Rachel L. Roper; Paul Bolin; Li V. Yang.

Article uri icon

publication date

  • 2025

number of pages

  • 1-14

start page

  • 1

end page

  • 14